Merck
MRK
$104.80
Share price
0.55%
Change (1 day)
29.05%
Change (1 year)
Categories
Merck (MRK) - Total assets
Total assets on the balance sheet as of December 2022 : $109.16 B
According to Merck's latest financial reports the company's total assets are $109.16 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Merck - Total assets on balance sheet (from 2001 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $109.16 B | 3.28% |
| 2021-12-31 | $105.69 B | 15.4% |
| 2020-12-31 | $91.58 B | 8.52% |
| 2019-12-31 | $84.39 B | 2.13% |
| 2018-12-31 | $82.63 B | -5.96% |
| 2017-12-31 | $87.87 B | -7.87% |
| 2016-12-31 | $95.37 B | -6.29% |
| 2015-12-31 | $101.77 B | 3.5% |
| 2014-12-31 | $98.33 B | -6.92% |
| 2013-12-31 | $105.64 B | -0.46% |
| 2012-12-31 | $106.13 B | 0.96% |
| 2011-12-31 | $105.12 B | -0.62% |
| 2010-12-31 | $105.78 B | -5.63% |
| 2009-12-31 | $112.08 B | 137.5% |
| 2008-12-31 | $47.19 B | -2.39% |
| 2007-12-31 | $48.35 B | 8.48% |
| 2006-12-31 | $44.56 B | -0.62% |
| 2005-12-31 | $44.84 B | 5.34% |
| 2004-12-31 | $42.57 B | 4.89% |
| 2003-12-31 | $40.58 B | -14.66% |
| 2002-12-31 | $47.56 B | 8.08% |
| 2001-12-31 | $44.00 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 71.65% | 🇺🇸 USA |
 Novartis NVS | $117.45 B | 7.60% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 80.66% | 🇺🇸 USA |
 Abbott Laboratories ABT | $74.43 B | -31.81% | 🇺🇸 USA |
 Eli Lilly LLY | $49.48 B | -54.66% | 🇺🇸 USA |
 Amgen AMGN | $65.12 B | -40.34% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | 24.33% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $96.82 B | -11.30% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $72.89 B | -33.22% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $44.00 B | -59.69% | 🇮🇱 Israel |